Investigator studied current treatment patterns and attrition rates in metastatic clear cell renal cell carcinoma using a large, US nationwide cohort.

Gavin DeGraw wrote, “May God bless you brother. Showing us how to conquer the darkness with light.” Clear cell renal cell ...

The band’s third and fourth studio albums, “Seventeen Days” and self-titled fourth album both debuted atop the Billboard 200 ...

The following is a summary of “Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression,” published in the April 2025 issue of ...

PRINCE FREDERICK, Md. — The Calvert County Republican Central Committee (CCRCC) held a special closed-door meeting on Wednesday, March 12, 2025, at 7:00 p.m. at CCRCC Headquarters to vote on the ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Clear cell RCC (ccRCC) is almost universally associated with HIF-2a dysregulation. Casdatifan is currently being evaluated in ARC-20, a Phase 1/1b study in renal cell carcinoma and other cancers.

“I’d love for you to lift me up in prayer every chance you get,” he told fans. Clear cell renal cell carcinoma, or ccRCC, is ...

Study documents low use of immune checkpoint inhibitor-based combinations for first-line treatment of metastatic clear cell RCC and high attrition with subsequent therapy. Many patients with ...

Data from the Phase 1/1b ARC-20 study cohort evaluating casdatifan plus cabozantinib in immunotherapy (IO)-experienced patients with clear cell renal cell carcinoma (ccRCC) will be presented in an ...